Medical management of pulmonary actinomycosis: Data from 49 consecutive cases

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 4, 2009, Pages 839-841

  Kolditz, Martin ^a   Bickhardt, Jakob ^b   Matthiessen, Wolfgang ^c   Holotiuk, Olaf ^d   Höffken, Gert ^a,c   Koschel, Dirk ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Outpatient Pulmonology Center   (Germany)

^c Center for Pulmonology and Thoracic Surgery   (Germany)

^d Institute for Pathology   (Germany)

Author keywords

Antibiotics; Bronchoscopy; Dxycycline; Penicillin; Treatment duration

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLAVULANIC ACID; DOXYCYCLINE; IMIPENEM; PENICILLIN G;

ACTINOMYCOSIS; ADULT; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG INDICATION; DRUG REEXPOSURE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LEUKOPENIA; LUNG INFECTION; MALE; NEEDLE BIOPSY; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION; TRANSBRONCHIAL BIOPSY; TREATMENT DURATION; TREATMENT INDICATION;

ACTINOMYCOSIS; CASE MANAGEMENT; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED;

EID: 62549116583     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp016     Document Type: Letter

References (6)

1. Mabeza GF, Macfarlane J. Pulmonary actinomycosis. Eur Respir J 2003; 21: 545-51.
2. Yildiz O, Doganay M. Actinomycoses and Nocardia pulmonary infections. Curr Opin Pulm Med 2006; 12: 228-34.
3. Choi J, Koh WJ, Kim TS et al. Optimal duration of IV and oral antibiotics in the treatment of thoracic actinomycosis. Chest 2005; 128: 2211-7.
4. Hsieh MJ, Liu HP, Chang JP et al. Thoracic actinomycosis. Chest 1993; 104: 366-70.
5. Kinnear WJ, MacFarlane JT. A survey of thoracic actinomycosis. Respir Med 1990; 84: 57-9.
6. Yew WW, Wong PC, Lee J et al. Report of eight cases of pulmonary actinomycosis and their treatment with imipenem - cilastatin. Monaldi Arch Chest Dis 1999; 54: 126-9.